Skip to main content
Year archive

OSTEOPORE LIMITED — 2023 filings

All 74 regulatory filings released by OSTEOPORE LIMITED (OSX) in 2023, sourced directly from the official regulator.

74 Filings
2023 Period
2023 filings (74)
Filing Released Lang
Osteopore signs Bridging Loan agreement 3 pages 388.8KB
Capital/Financing Update
2023-12-27 English
Osteopore secures Hainan Approval for Neurosurgery 3 pages 464.5KB
Regulatory Filings
2023-12-17 English
Change of Director's Interest Notice - TSH 3 pages 217.8KB
Director's Dealing
2023-12-04 English
Negotiation ongoing for InnoVentures Definitive JV Agreement 2 pages 356.1KB
Capital/Financing Update
2023-11-29 English
Activities Update Qtr Ending September 2023 and Appendix 4C 20 pages 3.8MB
Interim / Quarterly Report Q3 2023
2023-10-30 English
Change of Director's Interest Notice 12 pages 569.1KB
Director's Dealing
2023-10-04 English
Investor Webinar Presentation 2 pages 358.7KB
Investor Presentation
2023-09-17 English
Clarification Announcement 3 pages 364.3KB
Capital/Financing Update
2023-09-17 English
MOU with Temasek-linked Innoventures - Orthopaedics in China 5 pages 407.5KB
Capital/Financing Update
2023-09-11 English
Resignation of Joint Company Secretary 1 page 345.9
Board/Management Information
2023-09-03 English
Half Yearly Report and Accounts 27 pages 990.7KB
Interim / Quarterly Report H1 2023
2023-08-30 English
Timeline extended for definitive agreements with CellHeal 2 pages 384.6KB
Capital/Financing Update
2023-08-28 English
Notification of cessation of securities - OSX 4 pages 23.8KB
Share Issue/Capital Change
2023-08-27 English
Investor Presentation 39 pages 8.3MB
Investor Presentation
2023-07-31 English
Clarification Announcement 3 pages 312.7KB
Capital/Financing Update
2023-07-31 English
Activities Update Qtr Ending June 2023 and Appendix 4C 26 pages 4.5MB
Interim / Quarterly Report Q2 2023
2023-07-30 English
Initial Director's Interest Notice - MK 3 pages 425.9KB
Director's Dealing
2023-07-30 English
OSX receives A$10m commitment for commercialisation in China 6 pages 413.2KB
Capital/Financing Update
2023-07-24 English
Osteopore strengthens Board & Management by key appointments 5 pages 419.7KB
Board/Management Information
2023-07-17 English
Rectification of Breach of ASX Listing Rule 10.11 1
Director's Dealing
2023-07-06 English
Change of Director's Interest Notice - ML 3 pages 201.9KB
Director's Dealing
2023-07-06 English
Application for quotation of securities - OSX 8 pages 32.9KB
Capital/Financing Update
2023-06-28 English
Notice of Breach of ASX Listing Rule 10.11 2 pages 275.1KB
Regulatory Filings
2023-06-25 English
Change of Share Registry Details 2 pages 243.5KB
Regulatory Filings
2023-06-22 English
Shortfall oversubscribed for Osteopore's Global Expansion 2 pages 317.6KB
Capital/Financing Update
2023-06-19 English
Strategic Partnership for Clinical R&D in China worth $4M 4 pages 288.7KB
Capital/Financing Update
2023-06-07 English
Results of Annual General Meeting 2 pages 296.3KB
Declaration of Voting Results & Voting Rights Announcements
2023-05-29 English
Notification regarding unquoted securities - OSX 7 pages 31.1KB
Share Issue/Capital Change
2023-05-24 English
Largest South African Medical Insurer provides cover for OSX 3 pages 299.5KB
Capital/Financing Update
2023-05-15 English
Notification regarding unquoted securities - OSX 7 pages 32.0KB
Share Issue/Capital Change
2023-05-11 English
Change of Registered Office 1 page 148.9KB
Regulatory Filings
2023-05-04 English
Activities Update Qtr Ending March 2023 and Appendix 4C 18 pages 3.6MB
Interim / Quarterly Report Q1 2023
2023-04-27 English
Notice of Annual General Meeting 35 pages 644.0KB
AGM Information
2023-04-27 English
Change of Director's Interest Notice - ML 3 pages 231.4KB
Director's Dealing
2023-04-27 English
Change of Director's Interest Notice - TSH 3 pages 234.6KB
Director's Dealing
2023-04-27 English
OSX Successfully transitions to EU Medical Device Regulation 2 pages 247.1KB
Regulatory Filings
2023-04-26 English
Top 20 and Distribution List - Options 4 pages 19.2KB
Major Shareholding Notification
2023-04-25 English
Reinstatement of Security Class to Quotation 1 page
Regulatory Filings
2023-04-25 English
Non-Renounceable Entitlement Offer - Results 2 pages 241.4KB
Capital/Financing Update
2023-04-23 English
Security Class Suspension from Quotation 1 page 425
Regulatory Filings
2023-04-23 English
Application for quotation of securities - OSX 8 pages 32.7KB
Capital/Financing Update
2023-04-23 English
Application for quotation of securities - OSX 6 pages 28.0KB
Share Issue/Capital Change
2023-04-23 English
Osteopore to Commercialise Innovative Bone Rengeneration Tec 4 pages 272.3KB
Capital/Financing Update
2023-04-13 English
Osteopore Increases Presence in Singapore Dental Market 3 pages 257.1KB
Capital/Financing Update
2023-04-13 English
Non-Renounceable Entitlement Offer - Closing Date 2 pages 274.3KB
Capital/Financing Update
2023-04-12 English
Employee Securities Incentive Plan 27 pages 383.4KB
Remuneration Information
2023-04-12 English
OSX Strengthens Presence in the Eastern Region of the USA 4 pages 246.1KB
Capital/Financing Update
2023-04-10 English
Annual General Meeting Date 1 page 279.5KB
AGM Information
2023-04-04 English
OSX Completes Acquisition to Accelerate Revenue Growth 3 pages 245.2KB
Capital/Financing Update
2023-03-30 English
Annual Report to Shareholders 61 pages 983.7KB
Annual Report FY 2022
2023-03-30 English
Appendix 4G and Corporate Governance Statement 21 pages 480.2KB
Regulatory Filings
2023-03-30 English
Results of General Meeting 2 pages 267.0KB
Declaration of Voting Results & Voting Rights Announcements
2023-03-30 English
Non-Renounceable Entitlement Offer Extension 2 pages 164.9KB
Capital/Financing Update
2023-03-29 English
Update - Proposed issue of securities - OSX 63 pages 797.8KB
Capital/Financing Update
2023-03-29 English
OSX Product Approved for Additional Applications in Taiwan 2 pages 202.8KB
Regulatory Filings
2023-03-26 English
Prospectus despatched 1 page 150.7KB
Capital/Financing Update
2023-03-20 English
Update - Proposed issue of securities - OSX 12 pages 46.1KB
Capital/Financing Update
2023-03-13 English
Non-Renounceable Entitlement Offer 4 pages 240.5KB
Capital/Financing Update
2023-03-12 English
Non-Renounceable Entitlement Offer Prospectus 63 pages 598.1KB
Capital/Financing Update
2023-03-12 English
Letter to Eligible Shareholders 3 pages 169.3KB
Capital/Financing Update
2023-03-12 English
Proposed issue of securities - OSX 13 pages 47.7KB
Capital/Financing Update
2023-03-12 English
Letter to Ineligible Shareholders 2 pages 150.3KB
Capital/Financing Update
2023-03-12 English
Letter to Optionholders 2 pages 149.3KB
Capital/Financing Update
2023-03-12 English
Notice of General Meeting/Proxy Form 56 pages 1.0MB
Proxy Solicitation & Information Statement
2023-03-01 English
Appendix 4E Preliminary Final Report 12 pages 215.5KB
Annual Report FY 2022
2023-02-27 English
Osteopore Advisory Panel of Distinguished Industry Leaders 5 pages 327.3KB
Board/Management Information
2023-02-26 English
Investor Presentation 28 pages 6.5MB
Investor Presentation
2023-02-19 English
OSX Enters Orthopaedic Market in Great Britain 3 pages 243.6KB
Regulatory Filings
2023-02-13 English
Activities Update Qtr Ending December 2022 and Appendix 4C 10 pages 636.1KB
Interim / Quarterly Report Q4 2022
2023-01-30 English
Appointment of Joint Company Secretary 1 page 165.2
Board/Management Information
2023-01-24 English
Integration of Acquired Business for Higher Sales & Margin 6 pages 264.9KB
M&A Activity
2023-01-22 English
Application for quotation of securities - OSX 6 pages 27.9KB
Share Issue/Capital Change
2023-01-03 English
Cleansing Notice 1 page 230.4KB
Capital/Financing Update
2023-01-03 English
Notification of cessation of securities - OSX 4 pages 24.6KB
Share Issue/Capital Change
2023-01-02 English